Two Sigma Securities, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

  • $10.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.21 - $0.43 $4,500 - $9,215
21,431 Added 59.88%
57,221 $12,000
Q3 2023

Nov 14, 2023
BUY
$0.28 - $0.93 $5,098 - $16,935
18,210 Added 103.58%
35,790 $10,000
Q2 2023

Aug 14, 2023
BUY
$0.55 - $1.26 $9,669 - $22,150
17,580 New
17,580 $12,000
Q4 2022

Feb 14, 2023
BUY
$1.02 - $7.48 $32,733 - $240,048
32,092 New
32,092 $37,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $556M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email